<DOC>
	<DOCNO>NCT02100969</DOCNO>
	<brief_summary>The purpose study determine whether Hizentra safe effective treatment people myasthenia gravis ( MG ) .</brief_summary>
	<brief_title>Open Label Study Subcutaneous Immunoglobulin ( SCIg ) Myasthenia Gravis</brief_title>
	<detailed_description>Myasthenia gravis ( MG ) rare autoimmune disorder cause muscle become weak immune system attack connection nerve muscle . Hizentra subcutaneous ( skin ) immunoglobin ( SCIg ) . An immunoglobin blood protein . Hizentra study treatment patient MG. Hizentra administer injection skin portable infusion pump , may easier patient administer current treatment . Participants ask complete 9 clinic visit 3 telephone call . It could take 30 week complete study visit .</detailed_description>
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Myasthenia Gravis</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Must MGFA MG grade 2 , 3 , 4 generalize MG , accord MGFA classification system Elevated AChR MuSK Ab Patient 's sign symptom well explain another disease process IVIg maintenance dose 0.2 2 gm/kg/4 week equivalent dose administer every 24 week Stable IVIg least 3 cycle Able complete study return followup visit Able give write informed consent participate study History chronic degenerative , psychiatric , neurologic disorder MG produce weakness fatigue Other major chronic debilitating illness within six month prior study entry Female patient premenopausal ( ) pregnant , ( b ) breastfeeding , ( c ) use effective method double barrier birth control Altered level consciousness , dementia , abnormal mental status Thymectomy previous three month History renal insufficiency liver disease Skin disease would interfere assessment injection site reaction History severe reaction IVIg SCIg Participation research study within last 3 month Treatment rituximab biologics within 12 month study entry Unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>MG</keyword>
	<keyword>Hizentra</keyword>
	<keyword>autoimmune neuromuscular disorder</keyword>
</DOC>